NORMAL SITUATION

Amylyx Pharmaceuticals Belgium

Company — Normal situation.

Financial year 2024 · Closed on 23/12/2024

Revenue73,9 k €
Equity10 €

Identity

Source · BCE/KBO

Amylyx Pharmaceuticals Belgium is a company registered in Belgium.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0805.901.734
Legal form
Private limited company
Contributed capital
10,00 €
Latest accounts
23/12/2024
Signals
Solid equity

Financials

Source · NBB, 1 filing

Trend over 1 financial year

2024
Income statement
Revenue73,9 k €
Balance sheet
Equity10 €
Total assets10 €

Board of directors

Source · NBB, accounts to 23/12/2024

2 active

Active mandates

James M. FRATES

Director

Active
Thomas J. HOLMES

Director

Active

Full financial information

Source · NBB
2024
Type of accountFull model
Start of the financial year15/09/2023
Closing of the financial year23/12/2024
Length of the financial year16 months
Filing date28/07/2025
General meeting23/12/2024
Currency of the financial yearEUR
NBB quality labelSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 1 filing
ModelClosingGeneral meetingFiledLanguageDocument
Full model23/12/202423/12/202428/07/2025FrenchPDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 23/12/2024

2 active

Active mandates

James M. FRATES

Director

Active
Thomas J. HOLMES

Director

Active

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Dissolution20/01/2025
    RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...)
    PDF
  • Mandates04/06/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Other07/12/2023
    DIVERS
    PDF
  • Other19/09/2023
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 2024